325 related articles for article (PubMed ID: 18184524)
1. Thrombotic microangiopathy in a 17-year-old patient: TTP, HUS or a bit of both?
Gerth J; Busch M; Oyen F; Schneppenheim R; Keller T; Budde U; Groene HJ; Wolf G
Clin Nephrol; 2007 Dec; 68(6):405-11. PubMed ID: 18184524
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
Shenkman B; Einav Y
Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Remuzzi G; Galbusera M; Noris M; Canciani MT; Daina E; Bresin E; Contaretti S; Caprioli J; Gamba S; Ruggenenti P; Perico N; Mannucci PM;
Blood; 2002 Aug; 100(3):778-85. PubMed ID: 12130486
[TBL] [Abstract][Full Text] [Related]
7. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
8. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
9. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Moake JL
Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
[TBL] [Abstract][Full Text] [Related]
10. Platelets: thrombotic thrombocytopenic purpura.
George JN; Sadler JE; Lämmle B
Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
[TBL] [Abstract][Full Text] [Related]
11. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
Licht C; Stapenhorst L; Simon T; Budde U; Schneppenheim R; Hoppe B
Kidney Int; 2004 Sep; 66(3):955-8. PubMed ID: 15327386
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
[TBL] [Abstract][Full Text] [Related]
13. The molecular biology of thrombotic microangiopathy.
Tsai HM
Kidney Int; 2006 Jul; 70(1):16-23. PubMed ID: 16760911
[TBL] [Abstract][Full Text] [Related]
14. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
[TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms in thrombotic thrombocytopenic purpura.
Tsai HM
Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
[TBL] [Abstract][Full Text] [Related]
17. The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.
Bommer M; Wölfle-Guter M; Bohl S; Kuchenbauer F
Dtsch Arztebl Int; 2018 May; 115(19):327-334. PubMed ID: 29875054
[TBL] [Abstract][Full Text] [Related]
18. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
[TBL] [Abstract][Full Text] [Related]
19. [Thrombotic microangiopathies: thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Morphological features, differential diagnosis, and pathogenesis].
Honsová E
Cesk Patol; 2008 Jul; 44(3):54-8. PubMed ID: 18783134
[TBL] [Abstract][Full Text] [Related]
20. HUS and TTP: traversing the disease and the age spectrum.
Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G
Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
